Lixa was established in 2021 with a focus on developing scalable antibiofilm technologies to treat antimicrobial resistance (AMR).
In 2022, Lixa won the Wesfarmers award for its Neo X platform technology at the WA Innovator of the Year Awards.
NEWS: Tagged in Lixa move NeoX-101 to clinical trials | 18 Nov 2024 | |
NEWS: Tagged in Bridging WA's Innovation to Commercialisation Gap | 09 Sep 2024 | |
NEWS: Tagged in Medtech startup Neurotologix wins WA Innovator of the Year | 05 Dec 2022 | |
NEWS: Tagged in Lixa targets global biotech market | 01 Sep 2022 | |
ADDED: Added to Startups list | 25 Aug 2022 | |
NEW ROLE: Andrew Barker, Chief Scientific Officer | 25 Aug 2022 | |
NEW ROLE: Craig Ridley, Director, Company Secretary, Chief Financial Officer | 25 Aug 2022 | |
NEW ROLE: Angela Fonceca, Co-Founder, Chief Operating Officer, Director | 25 Aug 2022 | |
NEW ROLE: Maud Eijkenboom, Co-Founder, Chief Executive, Director | 25 Aug 2022 |